Metadherin Promotes the Development of Bladder Cancer by Enhancing Cell Division

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Bladder cancer (BLCA) is a significant malignancy.
• The role of Metadherin (MTDH) in BLCA progression is not fully understood.
• Investigating MTDH's molecular mechanisms is crucial for BLCA treatment.

Purpose of the Study:

• To elucidate the molecular biological functions of Metadherin (MTDH) in bladder cancer (BLCA).
• To determine the effect of MTDH knockdown on BLCA cell behavior.
• To identify MTDH-related pathways and expression patterns in BLCA.

Main Methods:

• Short hairpin RNAs and small interfering RNAs were used to silence MTDH in BLCA cells.
• RNA sequencing (RNA-seq) was performed on MTDH-knockdown T24 cells.
• MTDH mRNA and protein expression levels were analyzed in BLCA tissues using multiple detection methods.

Main Results:

• MTDH knockdown significantly inhibited BLCA cell proliferation, viability, and migration, while inducing apoptosis.
• RNA-seq revealed that MTDH knockdown impacts extracellular matrix organization and cell division pathways.
• Integrated analysis of 1485 BLCA and 180 non-BLCA samples showed MTDH expression at mRNA (0.47) and protein (0.54) levels.

Conclusions:

• Metadherin (MTDH) promotes bladder cancer (BLCA) cell growth, particularly through the cell division pathway.
• MTDH serves as a potential biomarker and therapeutic target for bladder cancer.
• This research offers new directions for future BLCA treatment strategies.